VF
ARCT icon

Virtu Financial’s Arcturus Therapeutics ARCT Stock Holding History

Virtu Financial’s Portfolio ARCT Stock Details ARCT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-10,192
Closed -$248K – 1346
2024
Q2 		$248K Buy
+10,192
New +$309K 0.02% 643
2023
Q4 		– Sell
-23,445
Closed -$599K – 1544
2023
Q3 		$599K Buy
+23,445
New +$722K 0.06% 293
2018
Q1 		– Sell
-10,811
Closed -$86K – 1928
2017
Q4 		$86K Buy
+10,811
New +$97.2K ﹤0.01% 1954

Other funds holding ARCT

Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $69.6B AUM 42.52% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
NAMA
Nikko Asset Management Americas New York $7.75B AUM 33.73% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $15.4B AUM 50.29% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
WP
Woodline Partners San Francisco, California $32.4B AUM 58.5% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Virtu Financial's ARCT Position: Q3 2024 in Review

Virtu Financial sold out of Arcturus Therapeutics (ARCT) in Q3 2024, closing a stake of 10,192 shares — an estimated $248K sold.

Virtu Financial first reported a position in ARCT in Q4 2017 and held it in 3 quarters. The position peaked at $599K in Q3 2023. 164 funds tracked by Wall St. Rank hold ARCT as of Q3 2024.

  • Virtu Financial reported no remaining Arcturus Therapeutics position as of Q3 2024 after selling out during the quarter.
  • Virtu Financial sold 10,192 Arcturus Therapeutics shares in Q3 2024, an estimated $248K.
  • Virtu Financial first reported a position in Arcturus Therapeutics in Q4 2017 and held it in 3 quarters.
  • Virtu Financial's Arcturus Therapeutics position peaked at $599K in Q3 2023.
  • 164 funds tracked by Wall St. Rank held Arcturus Therapeutics as of Q3 2024.

Based on Virtu Financial's 13F filing for Q3 2024, filed 20 Nov 2024.